Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Sanofi 13.284, CSL 3.6525.
* CSL reports semi-annually. Values are evenly split across both quarters within each half.
Sanofi vs CSL Net Worth and Market Cap
Sanofi (SNY) and CSL (CSL.AX) are peers in Vaccines. Sanofi reported revenue of $13.3B as of Q2 2026, compared with $7.3B for CSL. Sanofi leads on revenue.
Sanofi's gross margin is 75.5% versus 44.4% for CSL. Sanofi's net margin is 2.8% versus -40.2% for CSL.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Sanofi, CSL.| Metric | Sanofi | CSL |
|---|---|---|
| Market Cap | - | - |
| Revenue | $13.28B | $7.30B |
| Cost of Revenue | $3.26B | $4.06B |
| Gross Profit | $10.03B | $3.24B |
| Operating Income | $2.58B | $1.39B |
| Net Income | $370.00M | $-2.94B |
| R&D Expense | $2.41B | $614.00M |
| Earnings Per Share | $0.15 | -$6.14 |
| Gross Margin | 75.5% | 44.4% |
| Operating Margin | 19.4% | 19.0% |
| Net Profit Margin | 2.8% | -40.2% |
| Free Cash Flow | $4.22B | $1.76B |
| Cumulative Free Cash Flow | $51.81B | $21.56B |
| Operating Cash Flow | $5.85B | $2.09B |
| Cash & Equivalents | $6.86B | $1.51B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.